Published in Biomaterials on February 22, 2014
Thiol-norbornene photo-click hydrogels for tissue engineering applications. J Appl Polym Sci (2015) 0.86
Harnessing developmental processes for vascular engineering and regeneration. Development (2014) 0.82
Inhibition of apoptosis in human induced pluripotent stem cells during expansion in a defined culture using angiopoietin-1 derived peptide QHREDGS. Biomaterials (2014) 0.78
Simple polyacrylamide-based multiwell stiffness assay for the study of stiffness-dependent cell responses. J Vis Exp (2015) 0.78
Self-assembly of cationic multidomain peptide hydrogels: supramolecular nanostructure and rheological properties dictate antimicrobial activity. Nanoscale (2015) 0.77
Deconstructing the role of the ECM microenvironment on drug efficacy targeting MAPK signaling in a pre-clinical platform for cutaneous melanoma. Biomaterials (2015) 0.77
A synthetic modular approach for modeling the role of the 3D microenvironment in tumor progression. Sci Rep (2015) 0.76
PEG-chitosan hydrogel with tunable stiffness for study of drug response of breast cancer cells. Polymers (Basel) (2016) 0.75
PEG-peptide hydrogels reveal differential effects of matrix microenvironmental cues on melanoma drug sensitivity. Integr Biol (Camb) (2017) 0.75
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med (2011) 45.46
Matrix elasticity directs stem cell lineage specification. Cell (2006) 43.00
Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med (2010) 36.57
Tensional homeostasis and the malignant phenotype. Cancer Cell (2005) 19.30
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity. Proc Natl Acad Sci U S A (2008) 17.41
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature (2010) 16.12
Taking cell-matrix adhesions to the third dimension. Science (2001) 15.21
Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell (2009) 14.40
Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med (2012) 13.17
Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer (2005) 8.70
A tense situation: forcing tumour progression. Nat Rev Cancer (2009) 7.80
Modeling tissue morphogenesis and cancer in 3D. Cell (2007) 7.49
Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng (2009) 4.72
Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases. Mol Cancer Ther (2006) 4.57
PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells. Pigment Cell Melanoma Res (2010) 4.50
Thiol-ene click chemistry. Angew Chem Int Ed Engl (2010) 4.42
Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res (1990) 4.22
Apoptosis and melanoma chemoresistance. Oncogene (2003) 3.58
Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene (2009) 3.17
A Versatile Synthetic Extracellular Matrix Mimic via Thiol-Norbornene Photopolymerization. Adv Mater (2009) 3.07
Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials. J Clin Oncol (2000) 2.86
Materials science. Hydrogel cell cultures. Science (2007) 2.70
Photoinitiated polymerization of PEG-diacrylate with lithium phenyl-2,4,6-trimethylbenzoylphosphinate: polymerization rate and cytocompatibility. Biomaterials (2009) 2.65
The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when combined with docetaxel. Clin Cancer Res (2008) 2.64
BRAF silencing by short hairpin RNA or chemical blockade by PLX4032 leads to different responses in melanoma and thyroid carcinoma cells. Mol Cancer Res (2008) 2.57
Akt3-mediated resistance to apoptosis in B-RAF-targeted melanoma cells. Cancer Res (2010) 2.42
HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment. Breast Cancer Res Treat (2009) 2.34
Life isn't flat: taking cancer biology to the next dimension. In Vitro Cell Dev Biol Anim (2006) 2.32
Enhanced proteolytic degradation of molecularly engineered PEG hydrogels in response to MMP-1 and MMP-2. Biomaterials (2010) 2.29
Three-dimensional tissue culture models in cancer biology. Semin Cancer Biol (2005) 2.26
The use of poly(ethylene glycol) hydrogels to investigate the impact of ECM chemistry and mechanics on smooth muscle cells. Biomaterials (2006) 2.23
PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas. Pigment Cell Melanoma Res (2010) 2.02
Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials (2010) 1.95
The performance of human mesenchymal stem cells encapsulated in cell-degradable polymer-peptide hydrogels. Biomaterials (2011) 1.75
Applications of optical coherence tomography in dermatology. J Dermatol Sci (2005) 1.72
Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cells. J Clin Endocrinol Metab (2009) 1.59
B-RAF and PI-3 kinase signaling protect melanoma cells from anoikis. Oncogene (2006) 1.39
The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs. Biomaterials (2011) 1.30
3D in vitro bioengineered tumors based on collagen I hydrogels. Biomaterials (2011) 1.26
A simple indentation device for measuring micrometer-scale tissue stiffness. J Phys Condens Matter (2010) 1.22
Small peptide functionalized thiol-ene hydrogels as culture substrates for understanding valvular interstitial cell activation and de novo tissue deposition. Acta Biomater (2012) 1.16
Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma. Crit Rev Oncol Hematol (2002) 1.11
Tumor-derived fibronectin is involved in melanoma cell invasion and regulated by V600E B-Raf signaling pathway. J Invest Dermatol (2006) 1.09
Cellular origin and developmental mechanisms during the formation of skin melanocytes. Exp Cell Res (2010) 0.91
The surgical treatment of stage I cutaneous melanoma. Cancer Treat Rev (1978) 0.81
A pilot study evaluating real-time shear wave ultrasound elastography of miscellaneous non-nodal neck masses in a routine head and neck ultrasound clinic. Ultrasound Med Biol (2012) 0.77